ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 211

Hopes and Fears of Patients with Axial Spondyloarthritis in Spain. the Value of Patient Opinion: Results from the Spanish Atlas

Marco Garrido-Cumbrera1, Pedro Plazuelo-Ramos2, Olta Brace1, David Galvez-Ruiz1 and Jorge Chacon-Garcia1, 1Universidad de Sevilla, Seville, Spain, 2CEADE, Madrid, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: doctor-patient relationship, patient preferences and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Health Services Research Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Not much attention has been paid to listening to the opinions of patients in most scientific studies on Spondyloarthritis, despite their opinions playing an increasingly important role in decision-making alongside clinical and public health criteria. To assess the opinions of patients with Axial Spondyloarthritis (ax-SpA) using qualitative information.

Methods: A sample of 680 patients diagnosed with ax-SpA was interviewed during 2016 as part of the Spanish Atlas, which aims to promote early referral and improve healthcare and the use of effective treatments in patients with ax-SpA. The Atlas is a CEADE initiative (Spanish Coordinator of Patients with ax-SpA in Spain) developed by the University of Seville and Max Weber Institute in collaboration with GRESSER (Spanish Rheumatology Society spondyloarthritis study group). Responses to qualitative items about patients’ hopes and fears for their disease and their personal aims regarding their treatment were analysed.

Results: 53% were females, mean age 46 years and 77.1% were HLA-B27+. The five main hopes of patients are: stopping the disease, dream of a cure, elimination of pain, improve their quality of life and live without limitations. Additionally, patients has expectations on the medical research outcomes. Thus, 81% of patients hope that the research will make possible to find the cause and a cure for ax-SpA, developing more efficient biologic therapies (11%), and finding new techniques or medication (8%). The following stand out among drug treatment-related concerns: having more effective treatments (32%), sustaining the results of biologic therapies (29%), being able to start on biologics (8%), the public health system funding non-drug treatments for AS (8%), eliminating secondary effects (15%), reducing prices (4%), and correct use (4%). With respect to their fears, patients stated that their main concern was mobility loss (31%), followed by loss of independence (23%), disability (22%), stiffness (12%), structural damage (3%), organ damage (3%), other illnesses and diseases related(3%), physical decline (3%), and sight loss (1%). Patients who expressed fear regarding their disease listed their greatest concern was that they would not overcome or tolerate pain (56%), followed by the fear that the disease would develop (32%), along with apprehension about flare-ups (7%), and tiredness (5%). With respect to patients’ personal objectives in terms of their treatments, they highlighted the wish that their treatment would, first, help them to reduce and eliminate pain, increasing their in mobility, improved quality of life, the avoidance of structural damage and the disease eventually being cured.

Conclusion: Analysis of patient opinion using qualitative information has enabled the identification of important concerns for patients such as discovering the cause of the disease, reducing pain and structural damage, loss of self-sufficiency and disability.


Disclosure: M. Garrido-Cumbrera, None; P. Plazuelo-Ramos, None; O. Brace, None; D. Galvez-Ruiz, None; J. Chacon-Garcia, None.

To cite this abstract in AMA style:

Garrido-Cumbrera M, Plazuelo-Ramos P, Brace O, Galvez-Ruiz D, Chacon-Garcia J. Hopes and Fears of Patients with Axial Spondyloarthritis in Spain. the Value of Patient Opinion: Results from the Spanish Atlas [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/hopes-and-fears-of-patients-with-axial-spondyloarthritis-in-spain-the-value-of-patient-opinion-results-from-the-spanish-atlas/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hopes-and-fears-of-patients-with-axial-spondyloarthritis-in-spain-the-value-of-patient-opinion-results-from-the-spanish-atlas/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology